Meridian Bioscience Inc was incorporated in Ohio in 1976. It is a fully-integrated life science company involved in the development, manufacture, sale and distribution of diagnostic test kits, mainly for certain respiratory, gastrointestinal, viral and parasitic infectious diseases. It also manufactures and distributes bulk antigens, antibodies and reagents used by researchers and other diagnostic manufacturers and the contract development. The Company is involved in manufacturing of proteins and other biological products used by bio-pharmaceutical and biotechnology companies engaged in research for new drugs and vaccines. The Companys operating segments are Diagnostics and Life Science. The Companys U.S. Diagnostics segment focuses on the development, manufacture, sale and distribution of diagnostic test kits, primarily for certain gastrointestinal, viral, respiratory and parasitic infectious diseases. Its European Diagnostics segment focuses on the sale and distribution of diagnostic test kits, manufactured both by the Companys U.S. Diagnostics segment and by third-party vendors. Life Science segment focuses on the development, manufacture, sale and distribution of bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells and bio-research reagents used by researchers and other diagnostic companies, as well as contract development and manufacturing services under clinical cGMP conditions. It has operations in Memphis, Tennessee; Boca Raton, Florida; London, England; Luckenwalde, Germany; and Sydney, Australia. The products in both segment includes Molecular tests, Immunoassay tests, Molecular components, Immunoassay components. The Companys competitors are Abbott Laboratories Inc., Becton, Dickinson and Company, Thermo Fisher and Siemens, Quidel Corporation and Inverness Medical Innovations. The diagnostic products are regulated by the Food & Drug Administration (FDA) as devices pursuant to the Federal Food, Drug, and Cosmetic Act (FDC).